Cargando…
TRIM24介导肺癌细胞吉非替尼耐药机制探讨
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance signifcantly limits its use in clinical practice. Study found that TRIM24 was overexpressed in non-small cell lung cancer (NSCLC) tissues and regulate cell growth, cell cycle and apoptosis in l...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999805/ https://www.ncbi.nlm.nih.gov/pubmed/26805734 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.01.03 |